These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34813608)
1. Sensitivity analysis of a reduced model of thrombosis under flow: Roles of Factor IX, Factor XI, and γ'-Fibrin. Chen J; Diamond SL PLoS One; 2021; 16(11):e0260366. PubMed ID: 34813608 [TBL] [Abstract][Full Text] [Related]
2. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa. Chen J; Diamond SL PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558 [TBL] [Abstract][Full Text] [Related]
3. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX. Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871 [TBL] [Abstract][Full Text] [Related]
4. Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI. Kearney KJ; Butler J; Posada OM; Wilson C; Heal S; Ali M; Hardy L; Ahnström J; Gailani D; Foster R; Hethershaw E; Longstaff C; Philippou H Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397811 [TBL] [Abstract][Full Text] [Related]
5. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Puy C; Tucker EI; Matafonov A; Cheng Q; Zientek KD; Gailani D; Gruber A; McCarty OJ Blood; 2015 Feb; 125(9):1488-96. PubMed ID: 25587039 [TBL] [Abstract][Full Text] [Related]
6. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow. Zhu S; Chen J; Diamond SL Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819 [TBL] [Abstract][Full Text] [Related]
7. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow. Zilberman-Rudenko J; Itakura A; Wiesenekker CP; Vetter R; Maas C; Gailani D; Tucker EI; Gruber A; Gerdes C; McCarty OJ Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):510-7. PubMed ID: 26769048 [TBL] [Abstract][Full Text] [Related]
8. General haemostatic agents--fact or fiction? Hedner U Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces. Zhu S; Lu Y; Sinno T; Diamond SL J Biol Chem; 2016 Oct; 291(44):23027-23035. PubMed ID: 27605669 [TBL] [Abstract][Full Text] [Related]
10. CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets. Döhrmann M; Makhoul S; Gross K; Krause M; Pillitteri D; von Auer C; Walter U; Lutz J; Volf I; Kehrel BE; Jurk K FASEB J; 2020 Jul; 34(7):9337-9357. PubMed ID: 32463151 [TBL] [Abstract][Full Text] [Related]
11. Evidence for factor IX-independent roles for factor XIa in blood coagulation. Matafonov A; Cheng Q; Geng Y; Verhamme IM; Umunakwe O; Tucker EI; Sun MF; Serebrov V; Gruber A; Gailani D J Thromb Haemost; 2013 Dec; 11(12):2118-27. PubMed ID: 24152424 [TBL] [Abstract][Full Text] [Related]
12. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation. Zivelin A; Ogawa T; Bulvik S; Landau M; Toomey JR; Lane J; Seligsohn U; Gailani D J Thromb Haemost; 2004 Oct; 2(10):1782-9. PubMed ID: 15456490 [TBL] [Abstract][Full Text] [Related]
18. Factor XI anion-binding sites are required for productive interactions with polyphosphate. Geng Y; Verhamme IM; Smith SA; Cheng Q; Sun M; Sheehan JP; Morrissey JH; Gailani D J Thromb Haemost; 2013 Nov; 11(11):2020-8. PubMed ID: 24118982 [TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose statin therapy on coagulation factors: Lowering of factor XI as a modifier of fibrin clot properties in coronary artery disease. Stępień K; Siudut J; Konieczyńska M; Nowak K; Zalewski J; Undas A Vascul Pharmacol; 2023 Apr; 149():107153. PubMed ID: 36774992 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa. Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]